NDC 16729-367-16 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-367
- Requested NDC
- 16729-367-16
- Package NDCs from labels
- 16729-367-10, 16729-367-15, 16729-367-16, 16729-367-17, 16729-367-45, 16729-367-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2024-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-367-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-367-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-367-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-367-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-367-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-367-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-367-10 | EA - Each | 16729-367 | aea7451f-249f-4002-a7df-f367e3bb0513 | 1 | 2020-09-14 |
| 16729-367-15 | EA - Each | 16729-367 | 0eff996a-5135-4a4b-a09e-70ccc66334d4 | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clinical Skin Filter Tinted Sunscreen | CLINICAL SKIN FILTER TINTED SUNSCREEN | KRX RESOURCES SDN. BHD. | 22b8856b-671f-def3-e063-6394a90a4ea0 | 2025-10-18 | Warnings | 15FIX9V2JP |
| Clinical Skin Filter Tinted Sunscreen Medium Dark | CLINICAL SKIN FILTER TINTED SUNSCREEN MEDIUM DARK | KRX RESOURCES SDN. BHD. | 22cead37-f862-e859-e063-6394a90a86ce | 2025-10-18 | Warnings | 15FIX9V2JP |
| Krx Aesthetics All Day Glow Sunblocker | KRX AESTHETICS ALL DAY GLOW SUNBLOCKER | KRX RESOURCES SDN. BHD. | 22a60fb9-0fea-92c0-e063-6394a90a088c | 2025-10-18 | Warnings | 15FIX9V2JP |
| DD Cream | DD CREAM | DERMAdoctor, Inc. | 08c9a0cf-ee78-483b-e054-00144ff88e88 | 2025-10-16 | Warnings | 15FIX9V2JP |
| Ciele Filter and Protect | TITANIUM DIOXIDE, ZINC OXIDE | Ciele | 0309b0ef-baca-b41d-e063-6294a90a49d7 | 2025-10-15 | Warnings | 15FIX9V2JP |
| Defend and Balance TInted Mineral Sunscreen SPF 50 | SUNSCREEN | Epicuren Discovery | 41367f05-59d8-6736-e063-6394a90a5f17 | 2025-10-15 | Warnings | 15FIX9V2JP |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 02752dae-30b7-4726-b22b-985b330a2060 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| olmesartan medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | 640936ee-55a6-47ae-a1ad-cffae316b925 | 2025-10-13 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Skinlycious Multi Protection Mineral Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE , ZINC OXIDE | Skinlycious Pte Ltd | e0ad02c3-f5ed-4b72-ba96-07d9c489a4ea | 2025-10-13 | Warnings | 15FIX9V2JP |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 3c001b8d-f6c1-4316-b8c0-590b2fa7f2e5 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Dr Lift Mineral SPF 50 | TITANIUM DIOXIDE, ZINC OXIDE | Spa de Soleil | 40c03d65-8d09-371a-e063-6294a90a7ac6 | 2025-10-09 | Warnings | 15FIX9V2JP |
| Dr Lift Mineral SPF 30 | TITANIUM DIOXIDE | Spa de Soleil | 40c0e0d2-2c1d-e629-e063-6394a90a5aaf | 2025-10-09 | Warnings | 15FIX9V2JP |
| OLMESARTAN MEDOXOMIL | OLMESARTAN MEDOXOMIL | A-S Medication Solutions | 38f7f201-3a3a-4922-bde7-d34187b4c81d | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Essential Defense Mineral Shield Broad Spectrum SPF 35 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Allergan, Inc. | 29817fdc-f14c-4013-a8ed-4367f3b2867c | 2025-10-09 | Warnings | 15FIX9V2JP |
| SPF50 Sunscreen | SUNSCREEN | KINGKEY MBC LIFE TECHNOLOGY GROUP CO., LTD | b3cde609-7d62-2ac7-e053-2a95a90a26b3 | 2025-10-07 | 15FIX9V2JP | |
| Avalide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Sanofi-Aventis U.S. LLC | 0d91895e-c869-4b33-9b83-d55c1ad6317e | 2025-10-07 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige | TITANIUM DIOXIDE | Toshiki Pigment Co., Ltd. | b9eba15f-493a-43c9-e053-2995a90a0451 | 2025-10-06 | Warnings | 15FIX9V2JP |
| PURE SOL SPF 37 Tinted Moisturizer | ZINC OXIDE TITANIUM DIOXIDE | Brand 2022b LLC | 4052c4e4-2105-80c0-e063-6294a90af41d | 2025-10-04 | Warnings | 15FIX9V2JP |
| Olmesartan Medoxomil | OLMESARTAN MEDOXOMIL | Bryant Ranch Prepack | e43e5643-b258-469d-812a-887f913cfe71 | 2025-10-03 | Boxed warning, Warnings, Adverse reactions | 6M97XTV3HD |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 0a34f28c-20e6-4f34-9c4a-70fb258aa300 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.